Bay-2666605
(6S)-5-[4-(4-fluorophenyl)-3-(trifluoromethyl)phenyl]-6-methyl-3,6-dihydro-1,3,4-oxadiazin-2-one
Molecular Identity
Bay-2666605
(6S)-5-[4-(4-fluorophenyl)-3-(trifluoromethyl)phenyl]-6-methyl-3,6-dihydro-1,3,4-oxadiazin-2-one
PubChem CID: 137465182
2D Structure
Properties
C17H12F4N2O2
Molecular Formula
352.28
Molecular Weight
g/mol
352.0835
Exact Mass
Da
4.5
XLogP
Drug-like (Lipinski: < 5)
50.7
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
7
H-Bond Acceptors
529
Complexity
SMILES
Canonical SMILES
SMILES: CC1C(=NNC(=O)O1)C2=CC(=C(C=C2)C3=CC=C(C=C3)F)C(F)(F)FIsomeric SMILES
SMILES: C[C@H]1C(=NNC(=O)O1)C2=CC(=C(C=C2)C3=CC=C(C=C3)F)C(F)(F)FSynonyms(20)
BAY-2666605BAY26666052H-1,3,4-Oxadiazin-2-one, 5-(4'-fluoro-2-(trifluoromethyl)(1,1'-biphenyl)-4-yl)-3,6-dihydro-6-methyl-, (6S)-RefChem:199713Schlafen12 Complex Inducer BAY 2666605SLFN12-PDE3A Complex Inducer BAY 2666605SLFN12/PDE3A Complex Inducer BAY 2666605BAY 26666052275774-60-0XC4ZA6OSY6UNII-XC4ZA6OSY6(6S)-5-[4-(4-fluorophenyl)-3-(trifluoromethyl)phenyl]-6-methyl-3,6-dihydro-1,3,4-oxadiazin-2-one(S)-5-(4'-Fluoro-2-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)-6-methyl-3,6-dihydro-2H-1,3,4-oxadiazin-2-oneorb1297869CHEMBL5268644
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Bay-2666605
Loading drug network...